Fla. Federal Judge Addresses Plaintiff’s Discovery Motion in Bevou Action



DOCUMENTS
  • Order


TAMPA, Fla. — A Florida federal magistrate judge has ordered Novartis Pharmaceuticals Corp. to produce documents spanning a five-year period in an action targeting its macular degeneration drug Beovu, ruling the discovery is not unreasonable or unduly burdensome.

In a June 17 order, Magistrate Judge Amanda Sansone of the U.S. District Court for the Middle District of Florida rejected the plaintiff’s request for documents spanning an 11-year time period, ruling he failed to establish that the end of the relevant time period for the allegations in his complaint extends past the date he stopped using Beovu.

Kenneth Davison was diagnosed …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: The Hottest Upcoming Device Projects - Strattice Hernia Mesh & Exactech Hip Implants

November 09, 2022

MORE DETAILS



HarrisMartin's MDL Conference: The Current Mass Tort Landscape - Best Management Practices & Updates on Key Litigation

September 28, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS